Yang Zhikai, Dong Jie
Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
Institute of Nephrology, Peking University, Beijing, China.
Clin Kidney J. 2020 Jul 4;13(3):322-327. doi: 10.1093/ckj/sfaa085. eCollection 2020 Jun.
Coronavirus disease 2019 (COVID-19) is an infectious respiratory disease caused by a novel coronavirus-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is spread from human to human and has resulted in a global pandemic, posing a disastrous public health risk worldwide. Patients with chronic kidney disease, especially those on dialysis, are considered to be at higher risk of developing severe COVID-19 due to their immunocompromised status and frail condition. The home treatment setting of peritoneal dialysis (PD) has advantages in terms of implementing self-care when routine hospital visits and social activities are restricted, thus greatly reducing exposure of PD patients to the virus.
We outline general operational considerations in PD management during the COVID-19 pandemic, including precautionary measures for PD patients and healthcare staff. Precautionary measures for PD patients include education on prevention of, and screening for, COVID-19, preclinic screening, in-clinic management, meticulous remote patient management and special hospitalization arrangements. The diagnosis and treatment of PD patients with COVID-19 are discussed. Precautionary measures for PD staff include continuous education on, and training in, COVID-19, exposure history surveillance and self-monitoring for COVID-19 among healthcare personnel, appropriate personal protective equipment and hand hygiene, organization of medical activities and staffing, and adequate environment cleaning.
This is a battle of the entire human society against the novel coronavirus. Integrated teamwork among healthcare providers, supported by society as a whole, is needed as part of the ongoing public health response to try to slow the spread of COVID-19.
2019年冠状病毒病(COVID-19)是一种由新型冠状病毒——严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的传染性呼吸道疾病。它在人与人之间传播,已导致全球大流行,给全球带来了灾难性的公共卫生风险。慢性肾脏病患者,尤其是接受透析治疗的患者,由于其免疫功能低下和身体虚弱,被认为感染重症COVID-19的风险更高。在常规医院就诊和社交活动受到限制时,腹膜透析(PD)的居家治疗模式在实施自我护理方面具有优势,从而大大减少了PD患者接触病毒的机会。
我们概述了COVID-19大流行期间PD管理的一般操作注意事项,包括针对PD患者和医护人员的预防措施。针对PD患者的预防措施包括COVID-19预防和筛查教育、诊前筛查、诊室内管理、细致的远程患者管理以及特殊住院安排。还讨论了PD合并COVID-19患者的诊断和治疗。针对PD工作人员的预防措施包括COVID-19持续教育和培训、医护人员COVID-19暴露史监测和自我监测、适当的个人防护装备和手卫生、医疗活动组织与人员配备以及充分的环境清洁。
这是整个人类社会与新型冠状病毒的一场战斗。作为当前公共卫生应对措施的一部分,需要医疗服务提供者之间的团队协作,并得到整个社会的支持,以努力减缓COVID-19的传播。